Last week, the European Medicines Agency announced plans to investigate
the safety of testosterone drugs. The announcement came in response to the
recent study from PLoS One, which found an increase in the risk for heart attack following
testosterone therapy. The Agency plans to review all available data on
the benefits and risks of testosterone therapy and then issue an opinion
on whether any changes should be made to their marketing authorizations.
The recent action taken by government agencies to investigate the safety
of testosterone products has huge implications for consumers around the
world. In the US, the FDA's investigation may result in a black box
warning requirement for testosterone products. A black box warning would
require drug companies to disclose information about the dangers of their
products to consumers.
Consumers who have not received adequate information about the risks of
testosterone drugs may have suffered serious injuries as a result. If
you or a loved one has suffered a heart attack, stroke, or blood clot
following testosterone use,
contact Morelli Law Firm immediately.